Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.
about
Mechanisms of the noxious inflammatory cycle in cystic fibrosisMicrobiology of airway disease in a cohort of patients with cystic fibrosis.Pseudomonas aeruginosa inhibits endocytic recycling of CFTR in polarized human airway epithelial cellsThe Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.Comparative efficacy and safety of 4 randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis.Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'Bdellovibrio bacteriovorus directly attacks Pseudomonas aeruginosa and Staphylococcus aureus Cystic fibrosis isolates.A pilot trial on safety and efficacy of erythrocyte-mediated steroid treatment in CF patientsUnfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA2-Aminoacetophenone as a potential breath biomarker for Pseudomonas aeruginosa in the cystic fibrosis lung.Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophilsNeutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.Expression of PPARĪ³ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.Clinical significance of microbial infection and adaptation in cystic fibrosis.Neutrophilic airway inflammation and IL-17.Pediatrics, surfactant, and cystic fibrosis in AJRCCM 2002.Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammationEarly airway infection, inflammation, and lung function in cystic fibrosis.Inflammatory markers of lung disease in adult patients with cystic fibrosis.Lung inflammation as a therapeutic target in cystic fibrosis.Future directions in early cystic fibrosis lung disease research: an NHLBI workshop reportEarly detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume testsAirway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.New insights into pulmonary inflammation in cystic fibrosis.Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammationEndpoints for clinical trials in young children with cystic fibrosis.Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.Galectin-9 signaling through TIM-3 is involved in neutrophil-mediated Gram-negative bacterial killing: an effect abrogated within the cystic fibrosis lung.Eradication of early Pseudomonas infection in cystic fibrosis.Mechanism of fibroblast inflammatory responses to Pseudomonas aeruginosa elastase.Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains.Lung function testing in preschool-aged children with cystic fibrosis in the clinical setting.Assessment and monitoring of cystic fibrosis lung disease in infants and young children.The cystic fibrosis neutrophil: a specialized yet potentially defective cell.
P2860
Q21284420-5381A453-8D51-4AAD-B1EF-16E100D298ACQ25256069-5438C26B-9E11-4BE9-9178-F0694C23AD94Q28492469-0D7A8533-4CFD-403F-8602-EC7A7653FD8DQ28492613-F90B36A9-336B-48E5-97D6-3795677C4822Q30413773-C7BD31AB-CA2D-4F98-9584-90349EA69552Q30434266-B6F64F1F-FF78-4808-9639-CABE659DFF43Q30436229-9243C361-0DD5-4DBD-BF33-4DA1D0283F5EQ30579959-CFB4F50C-920C-4C83-A0D8-166348508844Q30816650-7C91D0C2-16AF-40A8-842A-41F5B6F4B8EDQ33298018-72CC66DA-FC40-4139-843B-71255465B403Q33603047-E080C18D-FD21-41BF-8EF4-A07622372367Q33740049-27C1E263-D04D-425D-8918-B2CE976657F1Q33769610-F7561341-EC87-43AB-BB93-333A3A363730Q33788110-A7491511-7868-4136-AC34-13F8A617B22EQ34016539-66908FF6-6663-463D-BE6C-215749F7BC13Q34364700-41436804-C0C5-448E-BF1E-FA7E8A8680F2Q34426614-96B65BE0-AB34-4AB1-8A04-FB65F07FA5DEQ34491552-CBAC4468-D4DB-49D1-8A33-3704C8099FF7Q34778056-CCC4BA28-0793-4754-A7AF-DA77AFA5D2BBQ35055452-87AB2489-AED6-4C26-A1BA-66DE0A492FC9Q35173510-C5380AC4-B1D0-4466-A9D7-918E847F12D1Q35537438-453FA88F-8218-4FFC-8D0D-FE2C9C878E0BQ35571272-C00679C4-DB57-40A6-B789-E5798A6A1143Q35749974-6359F59D-4AB1-4992-B0E0-912A2E24365FQ35894285-57F32F0A-2660-45F2-8C2E-B7F7B55E0F1CQ35988949-FE7FE9E9-0A6A-496E-8B19-9ED7A5832848Q36166307-25B591C5-9C73-46DC-AEAB-182B9F06A108Q36216240-FD2E615B-70DF-4840-9211-305E5A1B6BA6Q36573117-2916140D-0253-420D-9DF6-9F21C9DB9009Q36853164-E839CDE6-DA23-4F1B-A8FC-B87AC458531AQ36891557-C3322A6E-5496-4881-8141-8B618551E5B2Q37125716-C47E95CF-6884-426D-AF46-7E8A9E6FA226Q37144524-D2EBE659-1C4F-4F99-AB9A-500E3F1E98BBQ37203240-9A316145-06F2-4D20-B9AA-C91C18A20F03Q37468065-588B2BDC-E61D-496E-AC16-373539B9FD61Q37629828-BF7B3ED5-29A7-42FD-8586-A047984AEA99Q37695294-1A2FBAA7-B7AF-46AD-AE11-45C21F03D165Q37738834-72D38878-1C99-4E0D-A081-47C767F8BB22Q37754879-9E41D4C3-35EC-406F-8AF7-A36214AE4025Q37839809-ABC990C7-5BC1-4E32-9D87-C88C20D754BC
P2860
Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis.
description
2002 nĆ® lÅ«n-bĆ»n
@nan
2002幓ć®č«ę
@ja
2002幓å¦ęÆęē«
@wuu
2002幓å¦ęÆęē«
@zh
2002幓å¦ęÆęē«
@zh-cn
2002幓å¦ęÆęē«
@zh-hans
2002幓å¦ęÆęē«
@zh-my
2002幓å¦ęÆęē«
@zh-sg
2002幓åøč”ęē«
@yue
2002幓åøč”ęē«
@zh-hant
name
Inflammation, infection, and p ...... children with cystic fibrosis.
@en
Inflammation, infection, and p ...... children with cystic fibrosis.
@nl
type
label
Inflammation, infection, and p ...... children with cystic fibrosis.
@en
Inflammation, infection, and p ...... children with cystic fibrosis.
@nl
prefLabel
Inflammation, infection, and p ...... children with cystic fibrosis.
@en
Inflammation, infection, and p ...... children with cystic fibrosis.
@nl
P2093
P2860
P1476
Inflammation, infection, and p ...... children with cystic fibrosis.
@en
P2093
Andrew H Numa
Calypso C Vertzyas
Carolyn J Dakin
John R Morton
Richard L Henry
P2860
P304
P356
10.1164/AJRCCM.165.7.2010139
P407
P577
2002-04-01T00:00:00Z